For the Inventor, By the Inventor

Enter assignee name

Valneva Se

USPTO Granted Patents = 13

EPO Patents = 4

Forward Citations = 31

Loading Chart...

Loading Chart...

16 inventors (with patents filed for the assignee):

Mario Nebenführ (8 out of 16 patents)

Jürgen Heindl-Wruss (8 out of 18 patents)

Michael Weber (7 out of 23 patents)

4. Robert Schlegl (7 out of 25 patents)

5. Jana Barbero Calzado (5 out of 13 patents)

6. Andreas Meinke (5 out of 45 patents)

7. Urban Lundberg (4 out of 19 patents)

8. Robert Schiegl (3 out of 4 patents)

9. Andrea Fritzer (3 out of 3 patents)

10. Arnaud Leon (3 out of 6 patents)

11. Klaus Heinrich Schwamborn (3 out of 9 patents)

12. Fabien Perugi (3 out of 3 patents)

13. Wolfgang Schüler (2 out of 12 patents)

14. Urban Lunberg (1 out of 1 patent)

15. Luc Batard (1 out of 1 patent)

13 patents: Sort by Forward Citations

1. 12214033 - Virus purification (2025-02-04),

2. 12162909 - Subunit vaccine for treatment or prevention of a respiratory tract infection (2024-12-10),

3. 12162907 - Subunit vaccine for treatment or prevention of a respiratory tract infection (2024-12-10),

4. 12053518 - Method for rescuing and producing a virus in avian cells (2024-08-06),

5. 12011477 - Method of producing pharmaceutical compositions comprising immunogenic chikungunya virus CHIKV-delta5NSP3 (2024-06-18),

6. 11629339 - Aseptic purification process for viruses (2023-04-18),

7. 11484587 - Method of producing pharmaceutical compositions comprising immunogenic Chikungunya virus CHIKV-Delta5nsP3 (2022-11-01),

8. 11406700 - Virus purification (2022-08-09),

9. 11357846 - Method of producing pharmaceutical compositions comprising immunogenic chikungunya virus CHIKV-Delta5NP3 (2022-06-14),

10. 11207397 - Virus purification (2021-12-28),

11. 10662412 - Aseptic purification process for viruses (2020-05-26),

12. 10660950 - Virus purification (2020-05-26),

13. 10537630 - Virus purification (2020-01-21),

Valneva is a specialty vaccine company focused on preventing infectious diseases with significant unmet medical need. The company has a growing portfolio of commercial vaccines and development programs, targeting travelers, endemic and orphan infectious diseases. Valneva's mission is to protect people from infectious diseases by developing and commercializing innovative vaccines.

This text is generated by artificial intelligence and may not be accurate.

Company Badge

USPTO Data Jan 1 1976 - Dec 30 2025

13 Patents

#9 in Nantes

#1,369 in France

#43,690 in the World

Valneva Se

Forward Citations = 31

16 inventors:

Mario Nebenführ (8 out of 16 patents)

Jürgen Heindl-Wruss (8 out of 18 patents)

Michael Weber (7 out of 23 patents)

4. Robert Schlegl (7 out of 25 patents)

5. Jana Barbero Calzado (5 out of 13 patents)

Please report any incorrect information to support@idiyas.com

Loading…